Bipartisan Congress Members Seek Clarity on Medical Cannabis Coverage Under Medicare

A bipartisan group of U.S. Congressional representatives has submitted a formal letter requesting clarification from the federal government regarding medical cannabis coverage under Medicare following the Drug Enforcement Administration's recent reclassification of cannabis. The inquiry addresses critical questions about patient eligibility, federal registry requirements, and how the reclassification will affect elderly and disabled Medicare beneficiaries who may benefit from medical cannabis therapies. This legislative action comes as states, including Puerto Rico, continue expanding medical cannabis programs while federal policy remains inconsistent. The Congress members seek federal guidance to ensure patients have clear access to medical cannabis treatments that may address chronic conditions and provide consistency across state lines.